These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28942457)

  • 21. An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu
    Marth K; Renner A; Langmayr G; Pohl W; Nguyen DT; Kuhl HC
    Drugs Real World Outcomes; 2024 Jun; 11(2):231-240. PubMed ID: 38351402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
    Harrow B; Sedaghat AR; Caldwell-Tarr A; Dufour R
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1426-1436. PubMed ID: 27882840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burden of allergic rhinitis and impact of MP-AzeFlu from the patient perspective: pan European patient survey.
    Canonica GW; Klimek L; Acaster S; Dollner R; Kaulsay R; Lo SH; Price DB; Scadding GK; Valovirta E; Zieglmayer P
    Curr Med Res Opin; 2021 Jul; 37(7):1259-1272. PubMed ID: 33840316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal Azelastine and Fluticasone as Combination Therapy for Allergic Rhinitis: Systematic Review and Meta-analysis.
    Debbaneh PM; Bareiss AK; Wise SK; McCoul ED
    Otolaryngol Head Neck Surg; 2019 Sep; 161(3):412-418. PubMed ID: 30961435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhinology future trends: 2017 EUFOREA debate on allergic rhinitis.
    Scadding G; Bousquet J; Bachert C; Fokkens WJ; Hellings PW; Prokopakis E; Pfaar O; Price D
    Rhinology; 2019 Feb; 57(1):49-56. PubMed ID: 30052697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis.
    van Weissenbruch R; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; Kuhl HC; Pohl W; Scadding GK; Price D; Mullol J
    J Asthma Allergy; 2020; 13():633-645. PubMed ID: 33293835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
    Bousquet J; Bachert C; Bernstein J; Canonica GW; Carr W; Dahl R; Demoly P; Devillier P; Hellings P; Fokkens W; Klimek L; Lieberman P; Meltzer E; Price D; Ryan D; Wahn U
    Expert Opin Pharmacother; 2015 Apr; 16(6):913-28. PubMed ID: 25747125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
    Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
    Klimek L; Mullol J; Hellings P; Gevaert P; Mösges R; Fokkens W
    Expert Opin Pharmacother; 2016; 17(5):657-69. PubMed ID: 26800187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
    Pulm Ther; 2023 Sep; 9(3):411-427. PubMed ID: 37580498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
    Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care.
    De Jong HJI; Voorham J; Scadding GK; Bachert C; Canonica GW; Smith P; Wahn U; Ryan D; Castillo JA; Carter VA; Murray RB; Price DB
    World Allergy Organ J; 2020 Dec; 13(12):100490. PubMed ID: 33376573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azelastine and fluticasone nasal spray: any advantage?
    Drug Ther Bull; 2014 Feb; 52(2):21-4. PubMed ID: 24504481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis.
    Klimek L; Bousquet J; Price D
    Expert Opin Drug Saf; 2016 Jan; 15(1):117-29. PubMed ID: 26581312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis.
    Demoly P; Bousquet PJ; Mesbah K; Bousquet J; Devillier P
    Clin Exp Allergy; 2013 Aug; 43(8):881-8. PubMed ID: 23889242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.
    Berger W; Sher E; Gawchik S; Fineman S
    Allergy Asthma Proc; 2018 Mar; 39(2):110-116. PubMed ID: 29490769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis.
    Katial RK; Oppenheimer JJ; Ostrom NK; Mosnaim GS; Yancey SW; Waitkus-Edwards KR; Prillaman BA; Ortega HG
    Allergy Asthma Proc; 2010; 31(1):68-75. PubMed ID: 20167147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US.
    Prenner BM
    J Asthma Allergy; 2016; 9():135-43. PubMed ID: 27468241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergic Rhinitis Control Test questionnaire-driven stepwise strategy to improve allergic rhinitis control: a prospective study.
    Wang Y; Chen H; Zhu R; Liu G; Huang N; Li W; Yang L; Zhang S; Qi S; Daurès JP; Chiriac AM; Demoly P
    Allergy; 2016 Nov; 71(11):1612-1619. PubMed ID: 27332957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel.
    Lipworth B; Newton J; Ram B; Small I; Schwarze J
    NPJ Prim Care Respir Med; 2017 Jan; 27(1):3. PubMed ID: 28115736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.